<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Court Allows Challenge to Patents on Breast Cancer Genes</title>
	<atom:link href="http://www.stlr.org/2009/11/court-allows-challenge-to-patents-on-breast-cancer-genes/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.stlr.org/2009/11/court-allows-challenge-to-patents-on-breast-cancer-genes/</link>
	<description></description>
	<lastBuildDate>Tue, 23 Apr 2013 18:27:00 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
	<item>
		<title>By: zubair279</title>
		<link>http://www.stlr.org/2009/11/court-allows-challenge-to-patents-on-breast-cancer-genes/comment-page-1/#comment-15137</link>
		<dc:creator>zubair279</dc:creator>
		<pubDate>Tue, 23 Nov 2010 18:21:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.stlr.org/?p=631#comment-15137</guid>
		<description>That was very informative and well written. Mentioned below is an article on gene patent debate:&lt;br&gt;&quot;The amicus brief submitted by the Department of Justice (DOJ) in the Breast Cancer Gene patent appeal before the Federal Circuit has drawn great attention during the last week. A US District Court had earlier rejected isolated gene sequence claims in Myriad&#039;s patent stating that they do not satisfy the patentable subject matter requirement because they are products of nature. Aggrieved by the decision of the District Court, Myriad appealed to the Federal Circuit. The Department of Justice has filed an amicus brief before the Federal Circuit stating that the District Court&#039;s opinion was right with respect to genomic DNA sequences. As the DOJ&#039;s opinion is very persuasive, it has once again brought the gene patent debate to life.&lt;br&gt;&lt;br&gt;The DOJ has clearly pointed out in its brief that cDNA sequences, vectors, recombinant plasmids and chimeric proteins are patentable but the genomic DNA sequence, which exists in human body is not patentable. As per DOJ, merely isolating the exact sequence as it exists in the body does not merit patent protection as it amounts to product of nature. The DOJ has in its brief logically pointed out that isolation of such a sequence and identifying the fact that it encodes a protein that causes breast cancer, which is a natural relationship, is not sufficient to make the sequence patentable.&quot;......read more at &lt;a href=&quot;http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html&quot; rel=&quot;nofollow&quot;&gt;http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p>That was very informative and well written. Mentioned below is an article on gene patent debate:<br />&#8220;The amicus brief submitted by the Department of Justice (DOJ) in the Breast Cancer Gene patent appeal before the Federal Circuit has drawn great attention during the last week. A US District Court had earlier rejected isolated gene sequence claims in Myriad&#39;s patent stating that they do not satisfy the patentable subject matter requirement because they are products of nature. Aggrieved by the decision of the District Court, Myriad appealed to the Federal Circuit. The Department of Justice has filed an amicus brief before the Federal Circuit stating that the District Court&#39;s opinion was right with respect to genomic DNA sequences. As the DOJ&#39;s opinion is very persuasive, it has once again brought the gene patent debate to life.</p>
<p>The DOJ has clearly pointed out in its brief that cDNA sequences, vectors, recombinant plasmids and chimeric proteins are patentable but the genomic DNA sequence, which exists in human body is not patentable. As per DOJ, merely isolating the exact sequence as it exists in the body does not merit patent protection as it amounts to product of nature. The DOJ has in its brief logically pointed out that isolation of such a sequence and identifying the fact that it encodes a protein that causes breast cancer, which is a natural relationship, is not sufficient to make the sequence patentable.&#8221;&#8230;&#8230;read more at <a href="http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html" rel="nofollow">http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: zubair279</title>
		<link>http://www.stlr.org/2009/11/court-allows-challenge-to-patents-on-breast-cancer-genes/comment-page-1/#comment-15138</link>
		<dc:creator>zubair279</dc:creator>
		<pubDate>Tue, 23 Nov 2010 18:21:28 +0000</pubDate>
		<guid isPermaLink="false">http://www.stlr.org/?p=631#comment-15138</guid>
		<description>That was very informative and well written. Mentioned below is an article on gene patent debate:&lt;br&gt;&quot;The amicus brief submitted by the Department of Justice (DOJ) in the Breast Cancer Gene patent appeal before the Federal Circuit has drawn great attention during the last week. A US District Court had earlier rejected isolated gene sequence claims in Myriad&#039;s patent stating that they do not satisfy the patentable subject matter requirement because they are products of nature. Aggrieved by the decision of the District Court, Myriad appealed to the Federal Circuit. The Department of Justice has filed an amicus brief before the Federal Circuit stating that the District Court&#039;s opinion was right with respect to genomic DNA sequences. As the DOJ&#039;s opinion is very persuasive, it has once again brought the gene patent debate to life.&lt;br&gt;&lt;br&gt;The DOJ has clearly pointed out in its brief that cDNA sequences, vectors, recombinant plasmids and chimeric proteins are patentable but the genomic DNA sequence, which exists in human body is not patentable. As per DOJ, merely isolating the exact sequence as it exists in the body does not merit patent protection as it amounts to product of nature. The DOJ has in its brief logically pointed out that isolation of such a sequence and identifying the fact that it encodes a protein that causes breast cancer, which is a natural relationship, is not sufficient to make the sequence patentable.&quot;......read more at &lt;a href=&quot;http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html&quot; rel=&quot;nofollow&quot;&gt;http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p>That was very informative and well written. Mentioned below is an article on gene patent debate:<br />&#8220;The amicus brief submitted by the Department of Justice (DOJ) in the Breast Cancer Gene patent appeal before the Federal Circuit has drawn great attention during the last week. A US District Court had earlier rejected isolated gene sequence claims in Myriad&#39;s patent stating that they do not satisfy the patentable subject matter requirement because they are products of nature. Aggrieved by the decision of the District Court, Myriad appealed to the Federal Circuit. The Department of Justice has filed an amicus brief before the Federal Circuit stating that the District Court&#39;s opinion was right with respect to genomic DNA sequences. As the DOJ&#39;s opinion is very persuasive, it has once again brought the gene patent debate to life.</p>
<p>The DOJ has clearly pointed out in its brief that cDNA sequences, vectors, recombinant plasmids and chimeric proteins are patentable but the genomic DNA sequence, which exists in human body is not patentable. As per DOJ, merely isolating the exact sequence as it exists in the body does not merit patent protection as it amounts to product of nature. The DOJ has in its brief logically pointed out that isolation of such a sequence and identifying the fact that it encodes a protein that causes breast cancer, which is a natural relationship, is not sufficient to make the sequence patentable.&#8221;&#8230;&#8230;read more at <a href="http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html" rel="nofollow">http://www.patentpill.com/2010/11/gene-patent-debate-is-alive-again.html</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dov Henis</title>
		<link>http://www.stlr.org/2009/11/court-allows-challenge-to-patents-on-breast-cancer-genes/comment-page-1/#comment-14379</link>
		<dc:creator>Dov Henis</dc:creator>
		<pubDate>Fri, 02 Apr 2010 19:28:30 +0000</pubDate>
		<guid isPermaLink="false">http://www.stlr.org/?p=631#comment-14379</guid>
		<description>Wives May Patent Husbands?
RNA Or DNA Genes, Organisms, Should Not Be Patentable
Organisms Should Not Be Patentable


Key Cancer Patents Killed
http://www.the-scientist.com/blog/display/57265/

All organisms, regardless of size, natural or modified by humans, should not be patentable.

Otherwise where is the limit???  

My wife of few years might yet apply to patent me...?!


Dov Henis
(Comments From The 22nd Century)
03.2010 Updated Life Manifest 
http://www.the-scientist.com/community/posts/list/54.page#5065</description>
		<content:encoded><![CDATA[<p>Wives May Patent Husbands?<br />
RNA Or DNA Genes, Organisms, Should Not Be Patentable<br />
Organisms Should Not Be Patentable</p>
<p>Key Cancer Patents Killed<br />
<a href="http://www.the-scientist.com/blog/display/57265/" rel="nofollow">http://www.the-scientist.com/blog/display/57265/</a></p>
<p>All organisms, regardless of size, natural or modified by humans, should not be patentable.</p>
<p>Otherwise where is the limit???  </p>
<p>My wife of few years might yet apply to patent me&#8230;?!</p>
<p>Dov Henis<br />
(Comments From The 22nd Century)<br />
03.2010 Updated Life Manifest<br />
<a href="http://www.the-scientist.com/community/posts/list/54.page#5065" rel="nofollow">http://www.the-scientist.com/community/posts/list/54.page#5065</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>
